|
AU2002364713A1
|
|
Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
|
|
AU2002357004A1
|
|
Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
|
|
US2003180804A1
|
|
Solid phase synthesis of chemical libraries
|
|
ZA200205678B
|
|
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon.
|
|
US2004001801A1
|
|
Conjugates activated by cell surface proteases and therapeutic uses thereof
|
|
ZA200203366B
|
|
Nucleic acids encoding endotheliases, endotheliases and uses thereof.
|
|
AU2002305052A1
|
|
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
AU3255802A
|
|
Compounds, compositions and methods for treatment of parasitic infections
|
|
CA2418199A1
|
|
Peptides as ns3-serine protease inhibitors of hepatitis c virus
|
|
WO0208256A2
|
|
Peptides as ns3-serine protease inhibitors of hepatitis c virus
|
|
US6777431B2
|
|
Non-convalent thrombin inhibitors
|
|
AU5540801A
|
|
Tetrahydro-azepinone derivatives as thrombin inhibitors
|
|
WO0179195A2
|
|
Pyridine and pyrazine derivatives as thrombin inhibitors
|
|
AU5541001A
|
|
Substituted hydrazinyl heteroaromatic inhibitors of thrombin
|
|
CA2396774A1
|
|
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
|
|
US2002037857A1
|
|
Non-covalent inhibitors of urokinase and blood vessel formation
|
|
WO0136351A2
|
|
Plasminogen activator inhibitor antagonists related applications
|
|
IL149340D0
|
|
Nucleic acids encoding endotheliases, endotheliases and uses thereof
|
|
WO0127141A1
|
|
Inhibitors of factor xa having an arginine or arginine aldehyde mimic
|
|
US6506754B1
|
|
Non-covalent thrombin inhibitors
|
